Biblio Discovery — Demo Discovery Service

4 hasil untuk "Li-Zhu Liao"

Menampilkan 1–4 · 0,30 detik · RSS

  1. Artikel Jurnal

    Quantitative phosphoproteomic analysis identifies the potential therapeutic target EphA2 for overcoming sorafenib resistance in hepatocellular carcinoma cells

    Chih-Ta Chen; Li-Zhu Liao; Ching-Hui Lu dkk.

    Experimental and Molecular Medicine, Vol. 52 No. 3 · 2020 · Inggris · DOAJ Scopus

    Liver cancer: A new route to fighting drug resistance Inhibiting the activity of a protein known as EphA2 may help overcome the development of drug resistance during treatment of hepatocellular carcinoma, the most common form of liver cancer. Resistance often develops to sorafenib, the main drug…

  2. Artikel Jurnal

    Histone 3 lysine 56 acetylation (H3K56ac) regulates extrachromosomal DNA (ecDNA) hub maintenance

    Li-Zhu Liao; Chang-Jiun Wu; Yu-An Chen dkk.

    Neoplasia: An International Journal for Oncology Research, Vol. 72 · 2026 · Inggris · DOAJ Scopus

    Extrachromosomal DNAs (ecDNAs) play an important role in tumor progression. ecDNA hubs have been shown to be anchored by BRD4, a chromatin reader. However, the chromatin organization of ecDNA hub remains unknown. Here we show that histone 3 lysine 56 acetylation (H3K56ac) mark binds to BRD4…

  3. Artikel Jurnal

    SPHK1 promotes bladder cancer metastasis via PD-L2/c-Src/FAK signaling cascade

    Wei-Hsiang Kao; Li-Zhu Liao; Yu-An Chen dkk.

    Cell Death and Disease, Vol. 15 No. 9 · 2024 · Inggris · DOAJ Scopus

    Abstract SPHK1 (sphingosine kinase type 1) is characterized as a rate-limiting enzyme in sphingolipid metabolism to phosphorylate sphingosine into sphingosine-1-phosphate (S1P) that can bind to S1P receptors (S1PRs) to initiate several signal transductions leading to cell proliferation and survival…